Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study

被引:0
|
作者
Patrick J. van der Geest
Nicole G. M. Hunfeld
Sophie E. Ladage
A. B. Johan Groeneveld
机构
[1] Erasmus University Medical Center,Department of Intensive Care Medicine
[2] Erasmus University Medical Center,Department of Pharmacy
来源
BMC Infectious Diseases | / 16卷
关键词
Critically ill; Micafungin; Anidulafungin; Invasive candidiasis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [11] Micafungin pharmacokinetic/pharmacodynamic adequacy for the treatment of invasive candidiasis in critically ill patients on continuous venovenous haemofiltration
    Maseda, Emilio
    Grau, Santiago
    Villagran, Maria-Jose
    Hernandez-Gancedo, Carmen
    Lopez-Tofino, Araceli
    Roberts, Jason A.
    Aguilar, Lorenzo
    Luque, Sonia
    Sevillano, David
    Gimenez, Maria-Jose
    Gilsanz, Fernando
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (06) : 1624 - 1632
  • [13] Clinical use of micafungin for the treatment of invasive candidiasis in critical ill patients
    Carlos Pozo-Laderas, Juan
    REVISTA IBEROAMERICANA DE MICOLOGIA, 2009, 26 (01): : 69 - 74
  • [14] Anidulafungin Versus Micafungin in the Treatment of Candidemia in Adult Patients
    Jin Woong Suh
    Sun Bean Kim
    Young Kyung Yoon
    Jang Wook Sohn
    Min Ja Kim
    Jong Hun Kim
    Mycopathologia, 2020, 185 : 653 - 664
  • [15] Micafungin in invasive candidiasis among oncohematological patients
    Jarque, Isidro
    Angel Sanz, Miguel
    REVISTA IBEROAMERICANA DE MICOLOGIA, 2009, 26 (01): : 75 - 77
  • [16] Intraabdominal candidiasis in surgical ICU patients treated with anidulafungin: A multicenter retrospective study
    Maseda, Emilio
    Rodriguez-Manzaneque, Marta
    Dominguez, David
    Gonzalez-Serrano, Matilde
    Mouriz, Lorena
    Alvarez-Escudero, Julian
    Ojeda, Nazario
    Sanchez-Zamora, Purificacion
    Granizo, Juan-Jose
    Gimenez, Maria-Jose
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2016, 29 (01) : 32 - 39
  • [17] A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis
    Benjamin, Daniel K., Jr.
    Kaufman, David A.
    Hope, William W.
    Smith, P. Brian
    Arrieta, Antonio
    Manzoni, Paolo
    Kovanda, Laura L.
    Lademacher, Christopher
    Isaacson, Brigit
    Jednachowski, Deborah
    Wu, Chunzhang
    Kaibara, Atsunori
    Walsh, Thomas J.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2018, 37 (10) : 992 - 998
  • [18] Resource Utilization and Cost of Treatment with Anidulafungin or Fluconazole for Candidaemia and Other Forms of Invasive CandidiasisFocus on Critically Ill Patients
    Annette C. Reboli
    Coleman Rotstein
    Daniel H. Kett
    Michael Maschio
    Shannon Cartier
    Richard Chambers
    Miriam Tarallo
    PharmacoEconomics, 2011, 29 : 705 - 717
  • [19] Update on invasive candidiasis in non-neutropenic critically ill adult patients
    Zaragoza, Rafael
    Ramirez, Paula
    Borges, Marcio
    Peman, Javier
    REVISTA IBEROAMERICANA DE MICOLOGIA, 2016, 33 (03): : 145 - 151
  • [20] Economic evaluation of micafungin versus caspofungin for the treatment of candidaemia and invasive candidiasis
    Neoh, C. F.
    Liew, D.
    Slavin, M. A.
    Marriott, D.
    Chen, S. C. -A.
    Morrissey, O.
    Stewart, K.
    Kong, D. C. M.
    INTERNAL MEDICINE JOURNAL, 2013, 43 (06) : 668 - 677